Robert J. Israel, Senior VP Medical Affairs at PROGENICS PHARMACEUTICALS INC (PGNX), sold 7,930 shares at $7.21 ($58K) on 2011-07-01, disclosed to the SEC on 2011-07-06.
Scheduled sale ($58k) by Senior VP Medical Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.21 | 1,000 | $7K | 12.3% |
| 2 | $7.40 | 6,930 | $51K | 87.7% |
| Total | $7.38 avg | 7,930 | $58K | 100% |
| Filing → |
| PGNX | SELL | 2015-03-13 | $14K | — | Filing → |
| PGNX | SELL | 2015-03-04 | $32K | — | Filing → |
| PGNX | SELL | 2015-01-13 | $14K | — | Filing → |